0
0
1/30/23 at 6:07pm
Organization
Contagionlive.com
Author
John Parkinson
26 words
0
Comments
The investigational therapy developed by Entasis is indicated for treatment of Acinetobacter baumannii.
You are the first to view
https://www.contagionlive.com/view/sulbactam-durlobactam-granted-priority-review-with-china-s-medical-regulatory-body
Create an account
or login to join the discussion